Skip to content

DHL Express Shipping

We ship 24 hours after your order !


Get tested in 4 simple steps


98%+ Accurate, Clinical studies proves the efficiency of our tests


Visa and MasterCard accepted

COVID-19 IgM/IgG Rapid Test

Medakit has developed and launched one of the world’s first rapid point-of-care lateral flow immunoassays for the diagnosis of coronavirus infection.

The test has been used widely by the Chinese CDC to combat infections and is now available globally. This test detects both early marker and late marker, IgM/IgG antibodies in human finger-prick or venous blood samples.

It can be used for rapid screening of carriers of the virus that are symptomatic or asymptomatic. Recent studies suggest that a high percentage of patients show no clinical symptoms of the virus, thus screening patients is vitally important. This test can be administered to anyone easily. The test can also be effectively deployed in businesses, schools, airports, seaports and train stations, etc., giving it the potential to become a compelling force in the fight against this global threat.

Medakit can produce more than 1,000,000 tests a day. 


To order, please contact us by email :

Features & Benefits

Medakit Rapid IgM-IgG Combined Antibody Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro.


  • Works with whole blood, serum, & plasma
  • Tests for both IgM and IgG antibodies
  • Sensitivity : 98.31% 
  • Specificity : 99.23%


  • 10-15 minutes per test
  • Intuitive visual interpretation
  • No special equipment needed
  • Easy to administer the test

How it works

4 Simple Steps

1. Collect blood sample from your finger using the lancet with the kit.

2. Add the blood sample to sample well.

3. Place 1 drop of buffer in sample well.

4. Read results after 15 minutes





Medakit new rapid test provides accurate COVID-19 infection diagnosis in 15 minutes.

It is widely accepted that IgM provides the first line of defense during viral infections, followed by the generation of adaptive, high affinity IgG responses for long term immunity and immunological memory. 

Therefore testing of COVID-19 IgM and IgG antibodies is an effective method for the rapid diagnosis of COVID-19 infection. Furthermore, detection of COVID-19 IgM antibodies tends to indicate a recent exposure to COVID-19, whereas detection of COVID-19 IgG antibodies indicates a later stage of infection. Thus, this combined antibody test could also provide information on the stage of infection.